Novus Group International Ab operates within the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novus Group International Ab with three other
miscellaneous service companies in Europe:
Fusion Antibodies PLC
of UNITED KINGDOM
(2020
sales of £3.90 million [US$5.29 million]
),
PHSC Plc
of UNITED KINGDOM
(£4.44 million [US$6.03 million]
), and
Reneuron Group PLC
which is
also
based in UNITED KINGDOM
(£6.07 million [US$8.24 million]
of which 100%
was Development of cell-based therapies).
Sales Analysis.
During the year ended June of 2020, sales at
Novus Group International Ab were SEK 55.94 million (US$6.67 million).
This
is
a
decrease of 0.3%
versus 2019, when the company's sales were SEK 56.14 million.